Atlas Trials

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Clinical trial NCT01400425 · COMPLETED

Trial details

NCT number
NCT01400425
Sponsor
Avid Radiopharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Progressive Cognitive Decline
Start date
2011-07-01
Primary completion
2012-07-01
Enrollment
239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.